Beiersdorf first quarter
This article was originally published in The Rose Sheet
Executive SummarySales of the consumer business segment, which includes Nivea, Eucerin and la prairie skin care brands, declined 0.5 percent on a like-for-like basis to $1.65 billion (€1=$1.30) in the first quarter, negatively impacted by destocking among retail partners, German company announces April 17. Operating results fell 15.8 percent to $187.5 million, the firm says. Noting skin care performance was "mixed," Beiersdorf adds "with the exception of Germany, a majority of markets in the major industrialized nations declined, while the rate of increase in growth markets such as China, Brazil, and Eastern Europe clearly slowed." However, the firm believes it will outperform the market in 2009 and deliver consumer sales "slightly" in excess of last year
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.